Steven Cobourn
Finanzdirektor/CFO bei NEXTCURE, INC.
Vermögen: - $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Steven Cobourn
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 23 | |
Otsuka America Pharmaceutical, Inc.
 Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America Pharmaceutical, Inc. manufactures and supplies pharmaceutical products. It develops drugs for neuroscience, cardiovascular, and gastrointestinal treatments. The company was founded in 1989 and is headquartered in Rockville, MD.
11
| Subsidiary | Pharmaceuticals: Major | 11 |
| Public Company | Biotechnology | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Steven Cobourn
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| GRITSTONE BIO, INC. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
| ARVINAS, INC. | Biotechnology | Chief Executive Officer Director/Board Member Chief Executive Officer | |
| Yale University | College/University | Doctorate Degree Graduate Degree Undergraduate Degree | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
Otsuka Pharmaceutical Co., Ltd.
 Otsuka Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Otsuka Pharmaceutical Co. Ltd. engages in the manufacturing, distributing, exporting, and importing of pharmaceuticals, clinical testing equipment, medical device and equipment, food products, cosmetics, and other related products. Its operations are carried out through the following business divisions: Pharmaceutical Business and Nutraceutical Business. The Pharmaceutical Business division engages in the manufacture and sale of pharmaceutical products for the diagnosis and treatment of diseases. The Nutraceutical Business division provides nutritional products, cosmetics and medicines that support day-to-day health maintenance and improvement. The company was founded on August 10, 1964 and is headquartered in Tokyo, Japan. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Chief Administrative Officer Corporate Officer/Principal Corporate Officer/Principal | |
Arvinas Operations, Inc.
 Arvinas Operations, Inc. BiotechnologyHealth Technology Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT. | Biotechnology | Chairman Director/Board Member Chief Executive Officer | |
| PIERIS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Chairman | |
| CYTOMX THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Yale School of Medicine | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Otsuka America, Inc.
 Otsuka America, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America, Inc. operates as a holding company for Otsuka America Pharmaceutical. Its primary objective is to bring products to the U.S. market developed by Otsuka America Pharmaceutical's Japanese parent company, Otsuka Pharmaceutical Co., Ltd. Those products center on treating neurological and cardiovascular diseases. The company was founded in 1989 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| University of California, Davis | College/University | Undergraduate Degree Doctorate Degree | |
| MACROGENICS, INC. | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal | |
| GENVEC INC | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
| University of Toronto | College/University | Undergraduate Degree Graduate Degree | |
| NABRIVA THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Nabriva Therapeutics GmbH
 Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Nabriva Therapeutics GmbH is a clinical-stage biopharmaceutical company, which engages in the research and development of novel anti-infective agents to treat serious infections. It focuses on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| HBM HEALTHCARE INVESTMENTS AG | Investment Managers | Director/Board Member Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| ONCORUS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
Tmunity Therapeutics, Inc.
 Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| The University of Connecticut School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
| INTERMUNE INC | Biotechnology | Director/Board Member Founder | |
| CELLDEX THERAPEUTICS, INC. | Medical/Nursing Services | Director/Board Member | |
| CURIS, INC. | Biotechnology | Director/Board Member | |
NiKang Therapeutics, Inc.
 NiKang Therapeutics, Inc. BiotechnologyHealth Technology NiKang Therapeutics, Inc. operates as biotechnology company. It focuses on developing novel small molecule oncology drug discovery. The company was founded by Zhenhai Gao and is headquartered in Wilmington, DE. | Biotechnology | Director/Board Member | |
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| JAZZ PHARMACEUTICALS PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Stritch School of Medicine | College/University | Doctorate Degree | |
| HUMANIGEN, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal | |
| University of Illinois | College/University | Undergraduate Degree | |
| EXELIXIS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| The University of Alabama at Birmingham | College/University | Undergraduate Degree | |
| Troy State University | College/University | Graduate Degree | |
| Vanderbilt University | College/University | Doctorate Degree | |
| Wofford College | College/University | Undergraduate Degree | |
Crossbow Therapeutics, Inc.
 Crossbow Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Crossbow Therapeutics, Inc. is a biotechnology company that aims to improve the lives of people with cancer by developing next-generation immunotherapies. The company is based in Cambridge, MA, and the CEO of the company is Briggs W. Morrison. The company's T-bolt™ therapies are designed to target previously unreachable cancer cell targets with high precision. Crossbow's approach is efficient and selective, allowing them to target the entire universe of cancer proteins, which expands the potential of antibody therapy to address many types of cancer. | Pharmaceuticals: Major | Chief Executive Officer | |
| CARISMA THERAPEUTICS, INC. | Biotechnology | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 43 |
| Irland | 3 |
| Japan | 2 |
| Deutschland | 2 |
| Kanada | 2 |
Sektoral
| Health Technology | 33 |
| Consumer Services | 14 |
| Technology Services | 2 |
| Finance | 2 |
| Commercial Services | 2 |
Operativ
| Director/Board Member | 238 |
| Corporate Officer/Principal | 83 |
| Independent Dir/Board Member | 81 |
| Chairman | 50 |
| Undergraduate Degree | 33 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Chau Khuong | 38 |
| Elaine Jones | 37 |
| David Kabakoff | 30 |
| Timothy Shannon | 28 |
| Ann Hanham | 26 |
| Briggs Morrison | 26 |
| Paul Freiman | 25 |
| Stephen Webster | 23 |
| Donald Hayden | 23 |
| Ellen Feigal | 16 |
| Mark Altmeyer | 16 |
| Michael Richman | 16 |
| Judith Li | 15 |
| Garry Nicholson | 14 |
| Stella Xu | 14 |
- Börse
- Insiders
- Steven Cobourn
- Unternehmensverbindungen
